Sonoma Pharmaceuticals (SNOA) Earnings Date, Estimates & Call Transcripts $3.02 +0.01 (+0.33%) Closing price 08/6/2025 03:59 PM EasternExtended Trading$2.76 -0.27 (-8.77%) As of 04:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Sonoma Pharmaceuticals Earnings Summary Sonoma Pharmaceuticals issued Q4 2025 earnings on June 17, 2025, reporting an EPS of -$0.15, which topped the consensus estimate of -$0.73 by $0.58. Quarterly revenue was reported to be $3.75 million, below analysts' expectations of $4.44 million. With a trailing EPS of -$3.10, Sonoma Pharmaceuticals' earnings are expected to decrease next year, from ($0.67) to ($1.79) per share. Q4 2025 Earnings ResourcesQ4 2025 Earnings ReportSNOA Upcoming EarningsSonoma Pharmaceuticals' next earnings date is estimated for Thursday, August 14, 2025, based on past reporting schedules. Upcoming Q1 Earnings DateAug. 14Before Market OpensEstimatedConsensus EPS (Jun. 17) -$0.73 Actual EPS (Jun. 17) -$0.15 Beat By $0.58 Actual Revenue (Jun. 17) $3.75M Get Sonoma Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sonoma Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataSNOA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SNOA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Sonoma Pharmaceuticals Analyst EPS EstimatesCurrent Year EPS Consensus Estimate ($0.67) EPSNext Year EPS Consensus Estimate ($1.79) EPS Sonoma Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/14/2025(Estimated)--------6/17/2025Q4 2025-$0.73-$0.15+$0.58-$0.48$4.44M$3.75M2/5/2025Q3 2025--$0.59--$0.63--11/7/2024---$0.59--$0.59-$3.58M8/8/2024--$0.06-$0.07 -$0.01-$0.07-$3.39M6/17/2024Q4 2024--$0.07--$0.07-$3.44M2/8/2024Q4 2023-$0.21-$0.06+$0.15-$0.04-$3.14M11/13/2023Q3 2023-$0.19-$0.20 -$0.01-$0.11-$2.73M8/10/2023Q1 2024--$0.29--$0.29-$3.43M Sonoma Pharmaceuticals Earnings - Frequently Asked Questions When is Sonoma Pharmaceuticals' earnings date? Sonoma Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 6th, 2025 based off last year's report dates. Learn more on SNOA's earnings history. Did Sonoma Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Sonoma Pharmaceuticals (NASDAQ:SNOA) reported ($0.15) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.73) by $0.58. Learn more on analysts' earnings estimate vs. SNOA's actual earnings. How much revenue does Sonoma Pharmaceuticals generate each year? Sonoma Pharmaceuticals (NASDAQ:SNOA) has a recorded annual revenue of $14.29 million. How much profit does Sonoma Pharmaceuticals generate each year? Sonoma Pharmaceuticals (NASDAQ:SNOA) has a recorded net income of -$3.46 million. SNOA has generated -$3.10 earnings per share over the last four quarters. What is Sonoma Pharmaceuticals' EPS forecast for next year? Sonoma Pharmaceuticals' earnings are expected to decrease from ($0.67) per share to ($1.79) per share in the next year. More Earnings Resources from MarketBeat Related Companies FNCH Earnings Date EQ Earnings Date RLMD Earnings Date ATNF Earnings Date NRSN Earnings Date BTAI Earnings Date CMMB Earnings Date HOTH Earnings Date PASG Earnings Date LEXX Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Rivian Takes Earnings Hit—R2 Could Be the Stock's 2026 LifelinePalantir Stock Soars After Blowout Earnings ReportVertical Aerospace's New Deal and Earnings De-Risk ProductionAmazon's Earnings: What Comes Next and How to Play ItApple Stock: Big Earnings, Small Move—Time to Buy?Why Robinhood Just Added Upside Potential After a Q2 Earnings DipMicrosoft Blasts Past Earnings—What’s Next for MSFT? This page (NASDAQ:SNOA) was last updated on 8/7/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sonoma Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sonoma Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
